glp 1 for ckd Current GLP-1 receptor agonists and recommendations in patients with GLP-1 receptor agonists in patients

"Unfortunately, many of these products have not been thoroughly tested or reviewed by the Food and Drug Administration, so we don't have data from trials

GLP-1s and Endurance Performance: What Athletes Need to Know Dec 10, 2025 GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) have quickly gained attention for their dramatic effects on weight loss and appetite control

Conversely, poor or unhealthy diets significantly contribute to global mortality, with dietary risks identified as one of the leading risk factors for death and disability, accounting for 20% of the cases worldwide (104)

Additionally, individuals who are overweight, with a BMI of 27 or higher, and additional health issues may also qualify for GLP treatment